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Abstract
Background: Routine measurement of Patient Reported Outcomes (PROs) linked with clinical data across the patient pathway
is increasingly important for informing future care planning. The innovative electronic Patient-reported Outcomes from Cancer
Survivors (ePOCS) system was developed to integrate PROs, collected online at specified post-diagnostic time-points, with
clinical and treatment data in cancer registries.
Objective: This study tested the technical and clinical feasibility of ePOCS by running the system with a sample of potentially
curable breast, colorectal, and prostate cancer patients in their first 15 months post diagnosis.
Methods: Patients completed questionnaires comprising multiple Patient Reported Outcome Measures (PROMs) via ePOCS
within 6 months (T1), and at 9 (T2) and 15 (T3) months, post diagnosis. Feasibility outcomes included system informatics
performance, patient recruitment, retention, representativeness and questionnaire completion (response rate), patient feedback,
and administration burden involved in running the system.
Results: ePOCS ran efficiently with few technical problems. Patient participation was 55.21% (636/1152) overall, although
varied by approach mode, and was considerably higher among patients approached face-to-face (61.4%, 490/798) than by telephone
(48.8%, 21/43) or letter (41.0%, 125/305). Older and less affluent patients were less likely to join (both P<.001). Most
non-consenters (71.1%, 234/329) cited information technology reasons (ie, difficulty using a computer). Questionnaires were
fully or partially completed by 85.1% (541/636) of invited participants at T1 (80 questions total), 70.0% (442/631) at T2 (102-108
questions), and 66.3% (414/624) at T3 (148-154 questions), and fully completed at all three time-points by 57.6% (344/597) of
participants. Reminders (mainly via email) effectively prompted responses. The PROs were successfully linked with cancer
registry data for 100% of patients (N=636). Participant feedback was encouraging and positive, with most patients reporting that
they found ePOCS easy to use and that, if asked, they would continue using the system long-term (86.2%, 361/419). ePOCS was
not administratively burdensome to run day-to-day, and patient-initiated inquiries averaged just 11 inquiries per month.
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Conclusions: The informatics underlying the ePOCS system demonstrated successful proof-of-concept – the system successfully
linked PROs with registry data for 100% of the patients. The majority of patients were keen to engage. Participation rates are
likely to improve as the Internet becomes more universally adopted. ePOCS can help overcome the challenges of routinely
collecting PROs and linking with clinical data, which is integral for treatment and supportive care planning and for targeting
service provision.
(J Med Internet Res 2013;15(10):e230)  doi: 10.2196/jmir.2764
KEYWORDS
cancer; oncology; patient reported outcomes; patient reported outcome measures; health-related quality of life; survivorship;
cancer registry; electronic data capture; health information technology; Internet
Introduction
In recent decades, the number of people living with and beyond
cancer has increased substantially [1]. Although there is
increasing understanding of survivorship outcomes, these will
not remain static as complex new treatments with unknown
long-term effects are introduced, and as the proportion of older
survivors with comorbid health and social care problems
increases [2]. In addition, new models for follow-up are being
encouraged that will include fewer patients being reviewed in
hospital and more patients self-managing their care [3]. The
escalating costs of cancer care in times of fiscal tightness augur
challenging decisions for service planners [4]. These decisions
must be determined by up-to-date real-world evidence, and this
is increasingly likely to include patient reported outcomes
(PROs) [5-7]. PROs may be collected to evaluate survivors’
reintegration in society, long-term needs, support requirements,
and quality of life and have application in multiple arenas: macro
(population surveillance), meso (cancer service delivery), and
micro (individual patient care) [8]. Health and social care
providers need to find sustainable, cost-efficient methods for
collecting PROs regularly, routinely, and at scale from across
the whole patient pathway in order to inform the evaluation of
future treatments and service planning. It is vital that providers
also find a means to efficiently and reliably link PROs to
patients’ clinical and treatment data, to help identify clinical
predictors of survivorship difficulties, and thus facilitate risk
stratification and targeted service provision.
Cancer registries and increasingly electronic health records
(EHR) [9,10] provide clinical, treatment, and some
sociodemographic data but do not routinely include PROs. A
number of large-scale mailed surveys have reported cancer
survivors’ functional and psychosocial well-being, lifestyle
behaviors, and supportive care needs with some of the surveys
using cancer registries for identification of survivors [11].
Traditionally, cancer registries have been used to record
incidence, prevalence, and survival using data collected
prospectively for all cancer patients. The role of registries is
evolving as registration data are now being linked with other
large electronic datasets, providing a rich source of
population-based data to inform service planning [12]. A recent
review has demonstrated increasing use of cancer registries in
quality of life studies of cancer survivors worldwide [13].
Online surveys are an obvious way forward (inexpensive and
widely used), but the challenges to their use in health care
include ensuring the involvement of all patients, obtaining
meaningful patient consent, combining PROs with medical
information, and maintaining data security. At the Eindhoven
cancer registry in the Netherlands, an online system has been
successfully established, complementing a mailed paper
questionnaire alternative, to collect and link PROs data to
registry data from patients identified via the registry post
registration: the Patient Reported Outcomes Following Initial
treatment and Long-term Evaluation of Survivorship
(PROFILES) system [14-16]. In order to collect PROs across
the whole patient pathway, patients need to be recruited soon
after diagnosis and thus pre-registration. One strategy for
identifying and recruiting patients close to diagnosis is via
hospitals. Use of electronic PROs early in the patient pathway
in cancer outpatient consultations has been shown to be feasible,
acceptable, and beneficial for patients [17-21]. Online systems
have also been used, with some success, for remote monitoring
of patients on follow-up [22]. Web-based PROs systems linked
to EHRs/cancer registries that patients consent to join close to
diagnosis in the clinical setting, potentially offer a sustainable
and scalable way forward for routinely collecting and linking
PROs with medical data over time. Ongoing increases in Internet
usage should help enable this approach. In Great Britain, 73%
of adults now use the Internet every day, although only 37% of
those over 65 years old use a computer daily [23]. Therefore,
although UK-based online PROs data collection systems for
home use are technologically achievable, their feasibility would
need to be carefully evaluated prior to implementation in regard
to patient response rates, as well as reliability and validity of
data collected, data security, and administrative burden [24].
We have designed and built a potentially UK-scalable system
for administering Patient Reported Outcome Measures (PROMs)
online at specified post-diagnostic time-points to patients
identified and consented in the clinical setting, for linking and
storing the collected PROs data with patients’ clinical data in
the regional registry, and for semiautomating the associated
patient monitoring and correspondence. This is the first such
system developed in the United Kingdom and is known as
electronic Patient-reported Outcomes from Cancer Survivors
(ePOCS). A comprehensive description of the design and
development of ePOCS has been published open-access and
includes a graphical representation of the system components
and data flows as well as details concerning data linkage [25].
The two key components of the ePOCS system are QTool, a
custom-designed Web-based password-protected questionnaire
administration and management system, and the Tracker, a
custom-designed database for monitoring patients’ QTool
activity and generating study correspondence (eg, invitations
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to complete questionnaires, reminders), which is housed on a
secure registry server. In brief, patients complete PROMs using
QTool, which is accessed via a public-facing website (Figures
1-4). The PROMs data are subsequently linked to patients’
clinical data transferred from the EHR to the registry and stored
in the National Cancer Data Repository. Monitoring of and
communications with patients (primarily by email) are
semiautomated via the Tracker (Figure 5).
This study aimed to test the technical and clinical feasibility of
the novel ePOCS system by running it in two UK National
Health Service (NHS) settings over 2 years. Feasibility outcomes
included system informatics performance, patient recruitment,
retention, representativeness and questionnaire completion
(response rate), patient feedback, and administration burden
involved in running the system.
Figure 1. Screenshot of the website homepage of the ePOCS system.
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Figure 2. Screenshot of the login page of the ePOCS system.
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Figure 3. Screenshot of an ePOCS system questionnaire item (item 7 from the 21-item Social Difficulties Inventory).
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Figure 4. Screenshot of an ePOCS system questionnaire item (item 3 from the 47-item Quality of Life in Adult Cancer Survivors scale).
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Figure 5. Screenshot of part of the ePOCS system Tracker, used to generate and send required daily patient correspondence (due invitations, reminders,
etc, appear in red).
Methods
Overview
Following ethical approval from the NHS Leeds (East) Research
Ethics Committee (ref. 10/H1306/65), a prospective,
repeated-measures feasibility study was run in the Yorkshire
Cancer Network (YCN) Cancer Centre and one YCN Cancer
Unit, in the United Kingdom. The comprehensive protocol for
the feasibility study has been published open-access [26].
Patients
Adult patients were eligible if diagnosed with potentially curable
breast, colorectal, or prostate cancer within the last 6 months
and were English literate. The target was to approach all eligible
patients during the recruitment period (November 2010 to
September 2011).
Recruitment Procedures
Eligible patients were identified during discussions in routine
multidisciplinary meetings and/or through consultation of
medical notes by NHS research nurses and/or oncology
clinicians, who then initially approached patients about study
participation. Wherever feasible, patients were approached and
informed about the study in-person, typically during a routine
hospital appointment. Where this was not possible (eg, patient
missed their appointment), patients were sent a letter about the
study signed by their consultant, or were sometimes telephoned
if the patient knew the recruiting research nurse/clinician.
Recruiting research nurses and clinicians completed a paper
form for each approached patient, on which they recorded,
among other things, the mode and location of approach.
Participants provided written informed consent, and their
consent status was recorded in the EHR [27] by the recruiting
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research nurse/clinician who also provided participants with
their ePOCS username and password. Patients who chose not
to join the study were not required to provide a reason why, but
where patients volunteered a reason, this was recorded by the
recruiting research nurse/clinician on the paper form (as was
“reason not given”). After consent, participants were followed
up by the ePOCS research team.
Follow-Up Procedures
When joining the study, patients were asked to provide an email
address that was used for all study correspondence (eg,
invitations to complete questionnaires, reminders). For patients
who did not provide an email address, all study correspondence
was mailed. Participants were asked to complete questionnaires
comprising multiple PROMs within 6 months of diagnosis (T1),
and at 9 months (T2) and 15 months (T3) post diagnosis. At T2
and T3, participants had up to 6 weeks to complete the
questionnaire. The PROMs chosen for each questionnaire were
typical of those likely to be used in future applications of the
system and covered various psychosocial and quality-of-life
issues ([28-35]; see Measures section below). The total number
of questionnaire items that participants were asked to complete
ranged between 80 and 154, dependent on time-point and cancer
site. At each time-point, a maximum of three email/letter
reminders were sent, and patients received a communication
thanking them for their participation (for those with any
outstanding PROMs, this included notification of the
questionnaire closing date). Prior to contacting participants at
T2 and T3, the ePOCS research team verified patient health
status.
A pen-and-paper feedback questionnaire devised by the
researchers and a prepaid addressed envelope were mailed to
all retained participants post T3. The feedback questionnaire
contained a mix of 28 closed and open questions chiefly
covering ease of use of various aspects of the system at the
different time-points, perceived positive aspects of the system,
and suggestions for system improvement. The full feedback
questionnaire is reproduced in Multimedia Appendix 1. The
questionnaire was mailed in order to keep feedback on the
system distinct from the system itself and to encourage as wide
and representative a response as possible, by facilitating
inclusion of patients who, although in the study, did not engage
or were no longer engaging with the online ePOCS system.
Throughout the study, the ePOCS research team diligently
maintained a “patient contact” log of all patient-initiated
inquiries to the team. For each inquiry (ie, each instance of
contact), among other things, the date, mode of communication
(eg, email, telephone, letter), and a detailed reason for the
contact were recorded on a database. The ePOCS system Tracker
automatically generates all the administrative actions due each
day (ie, all the patient invitations, reminders, thank yous, etc,
that need sending on that date). In order to test that the Tracker
was correctly generating all the necessary correspondence, the
research team also manually worked out all the administrative
actions due each day for 6 months at the study start and when
the first participants reached T2 and T3.
Measures
Illness Perception Questionnaire-Revised
The Illness Perception Questionnaire-Revised (IPQ-R) [28]
assesses patients’ personal beliefs and expectations about their
illness (eg, about its controllability and consequences) and
comprises nine subscales, eight of which were used in this study.
The IPQ-R (minus the omitted “causes” subscale) comprises
38 statements (eg, “my cancer is a serious condition”, “my
cancer will improve in time”) rated on a scale of 1 (strongly
disagree) to 5 (strongly agree), and 14 symptoms (eg,
“breathlessness”, “headaches”) rated on a yes/no scale, with
respect to patients’ views at the present moment.
EuroQol-5D, Version 2
The EuroQol-5D, version 2 (EQ-5Dv2) [29] is a 6-item generic
measure of health status that assesses mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression using a
3-option response format according to the severity of problems
experienced that day (no problems, some problems, severe
problems). The EQ-5Dv2 also includes a visual analogue scale
on which health state today is rated from 0 (worst imaginable
health state) to 100 (best imaginable health state).
Medical Outcomes Study 36-Item Short-Form Health
Survey, Version 2
The Medical Outcomes Study 36-Item Short-Form Health
Survey, version 2 (SF-36v2) [30] is a generic measure of health
status and functioning that assesses eight domains including
physical functioning, pain, and mental health. The measure
comprises 36 items (eg, “have you been happy”, “did you feel
worn out”) rated on a variety of Likert-type response scales (eg,
excellent to poor, all of the time to none of the time), primarily
with respect to the past 4 weeks.
Social Difficulties Inventory
The Social Difficulties Inventory (SDI-21) [31] assesses various
everyday difficulties commonly experienced by cancer patients,
including relationship difficulties, domestic problems, and
financial worries; 21 questions (eg, “have you felt isolated”,
“have you had any financial difficulties”) are answered on a 0
(no difficulty) to 3 (very much) scale with respect to the past
month.
European Organisation for Research and Treatment of
Cancer Quality of Life Questionnaire
The European Organisation for Research and Treatment of
Cancer (EORTC) Quality of Life Questionnaire (QLQ)
(EORTC-QLQ) [32-34] is a cancer-specific measure assessing
health-related functioning and symptoms that includes a generic
core questionnaire and numerous diagnosis specific modules.
This study used the breast (EORTC-QLQ-BR23), colorectal
(EORTC-QLQ-CR29), and prostate (EORTC-QLQ-PR25)
modules, each of which contain between 23 and 29 questions.
All EORTC-QLQ items (eg, “did you have a dry mouth”, “has
weight gain been a problem for you”) are rated on a scale of 1
(not at all) to 4 (very much) with respect to the past week or
month.
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Quality of Life in Adult Cancer Survivors Scale
The Quality of Life in Adult Cancer Survivors (QLACS) scale
[35] measures health-related quality of life in seven generic and
five cancer-specific domains, including cognitive problems,
social avoidance, and appearance. QLACS comprises 47 items
(eg, “you felt tired a lot”, “you had difficulty doing activities
that require concentrating”) rated on a scale of 1 (never) to 7
(always) with respect to the past 4 weeks.
Psychometric information about the measures and further
associated references are provided in the published study
protocol [26], as well as information about other study questions
that are not part of a standard validated PROM (eg, questions
about employment status, use of health, and social services).
Patients were asked to provide information about their ethnicity,
relationship status, and level of education in the T1
questionnaire, and other sociodemographic details (eg, gender,
age, postcode) and clinical information (eg, date and type of
cancer diagnosis, treatment regimens) were obtained from
participants’ medical records (following their explicit
permission, recorded on the consent form).
Study Outcomes
Informatics Performance: How Successful Are the
ePOCS System Informatics?
Technical success and reliability were evaluated by (1)
calculating the proportion of patients with successful linkage
of ePOCS PROs data and registry data, (2) comparing, and
subsequently exploring any discrepancy between, the manually
worked out administrative actions due each day (eg, the
invitations, reminders required) with those generated
automatically by the system Tracker, and (3) examining the
number and type of information technology (IT)-related patient
inquiries recorded in the “patient contact” log.
Recruitment and Representativeness: Do All Patients
Join Up to Use the ePOCS System?
Recruitment (ie, consent rate [CR]) was assessed by calculating
the proportion of eligible patients recruited relative to all eligible
patients approached. Potential differences in CR by mode of
approach (face-to-face, letter, telephone), and location (Cancer
Centre, Cancer Unit) were also explored. The representativeness
of recruited patients was assessed by examining differences in
sociodemographic and clinical characteristics between eligible
consenting patients and eligible approached patients who did
not join the study. The types and frequency of reasons for
nonparticipation, recorded by the consenting research nurses
and clinicians, were also analyzed.
Retention, Representativeness, and Questionnaire
Completion: Do All Patients Complete ePOCS
Questionnaires Fully and Repeatedly Over Time?
Retention was assessed by calculating the proportion of
consented patients still in study relative to all consented patients,
and the representativeness of retained patients was assessed by
examining differences in sociodemographic and clinical
characteristics between patients who remained in study and
patients who withdrew from the study.
Questionnaire completion, or the response rate (RR), was
assessed at all 3 time-points in two ways: RR1 is the number
of fully and partially completed questionnaires / all eligible
patients approached minus those who have died, and RR2 is
the number of fully and partially completed questionnaires / all
eligible consented patients minus those who have died.
We defined a fully completed questionnaire as one in which all
the items have been answered (ie, responded to, as patients
could choose to answer that they “prefer not to answer”), and
a partially completed questionnaire as one in which less than
all of the items have been answered (ie, one or more of the items
had no response).
Associations between patient characteristics and questionnaire
completion were explored.
For each PROM at each time-point, the proportion of missing
data, median completion time, and psychometric reliability were
also assessed. Missing data were calculated as the number of
“prefer not to answer” item responses within the total PROM
dataset (number of items in PROM multiplied by the number
of patients who fully completed the PROM).
Patient Feedback: What Do Patients Think About
Providing Data via ePOCS?
Participant opinion regarding ePOCS was evaluated from the
post-T3 feedback questionnaire. Closed questions were analyzed
using proportions. Free-text comments were read by the ePOCS
research team (HJ, LA, PW) and following discussion key
themes were agreed. The text was imported into QSR NVivo 9
with the main coding undertaken by HJ. Coding consistency,
coding saturation, and consensus discussions were undertaken
by PW and HJ. Quotes were grouped and examples chosen to
best represent the majority opinion for each theme.
Administration Burden: Is It Administratively Onerous
to Run the ePOCS System?
Administrative burden was assessed by examining (1) the
successful functioning of the Tracker system in automatically
generating the administrative actions due each day (eg, the
invitations, reminders required) (see feasibility outcome 1), as
this minimizes workload, (2) proportion of patients providing
an email address for study correspondence, as this too reduces
workload compared to printing and mailing study
correspondence, and (3) the dates, types, and frequency of
patient-initiated inquiries recorded in the "patient contact" log.
Quantitative data were analyzed using IBM-SPSS Statistics-19.
Group differences were examined using chi-square tests, t tests,
and binary logistic regression (alpha=0.05). Socioeconomic
status was determined using Index of Multiple Deprivation
(IMD) scores and quintiles calculated from patients’ postcodes
obtained from their medical records (February 2012 release)
[36]. PROMs internal reliability was assessed using Cronbach
alpha (≥0.70 acceptable).
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Results
Informatics Performance: How Successful Are the
ePOCS System Informatics?
The ePOCS system successfully linked PROs data with clinical
registry data for 100% of patients (N=636). Two key problems
were identified in the day-to-day running of ePOCS from the
comparison of the manually worked out administrative actions
due each day (eg, the number of invitations, reminders required
and for which particular patients) with those generated
automatically by the system Tracker. Some programming
updates to the EHR that were not notified in advance to the
ePOCS team affected registry data transfers, resulting in void
or inaccurate actions generated in the Tracker database. These
were resolved quickly. The second problem concerned date of
definitive diagnosis. The time-points for questionnaire
completion were determined from patients’ date of diagnosis
at the time of consent, which was entered into QTool (the
questionnaire administration component of the ePOCS system)
to guide the timing of questionnaire administration for each
patient. However, within the hospital EHR, patient diagnoses
can change following diagnostic tests, and when this happened,
a new diagnosis date was transferred to the Tracker (the patient
monitoring and correspondence component of the ePOCS
system), which was different from the original diagnosis date
entered into QTool, thus causing QTool-Tracker asynchrony.
This resulted in 8 (0.7%) missed invitations of 1227 due.
Additional system programming prevented the “original”
diagnosis date taken at the time of consent and used in QTool
from being overwritten in the Tracker, thus resolving the
problem. The majority of IT-related inquiries from participants
using the system (n=86) concerned issues with logging on, and
notably, confusion between similar-looking (eg, zero/letter o)
and case-sensitive letters/numbers in usernames/passwords.
Recruitment and Representativeness: Do All Patients
Join Up to Use the ePOCS System?
Of 1152 eligible patients approached, 636 consented to
participate (55.21%). Patient recruitment is detailed in Figure
6. The most effective recruitment strategy was face-to-face in
clinic (61.4%, 490/798) compared with letter (41.0%, 125/305),
and telephone (48.8%, 21/43). For 6 patients the mode of
approach was not recorded. Recruitment was higher at the
Cancer Centre (61.1%, 510/835) than at the Unit (39.7%,
126/317), and there was a significant association between
recruitment strategy and location, with letters employed more
frequently at the Unit (38.3%, 121/316) than Centre (22.2%,
184/830) (all three χ2, P<.001).
Participants (mean 61.3, SD 11.09 years) were significantly
younger than declining patients (mean 66.0, SD 12.05 years;
t1150=-6.903, P<.001), and significantly more affluent (missing
value=1; χ24=22.106, P<.001, n=1151). No differences were
found by gender (P=.88), diagnosis (P=.21) or time post
diagnosis (P=.21). Only active decliners had the opportunity
to provide a reason for declining participation. Of these, 61/329
(18.5%) provided no reason for nonparticipation. The majority
(71.1%, 234/329) gave IT reasons for nonparticipation (eg, no
computer/Internet access, do not like computers). Participant
characteristics are shown in Table 1.
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Table 1. Clinical and sociodemographic characteristics of participants.
Total
N=636
n (%)
Cancer Unit
n=126
n (%)
Cancer Centre
n=510
n (%)
Characteristic
Collected at time of consent (N=636)
Cancer diagnosis
297 (46.7)69 (54.8)228 (44.7)Breast
192 (30.2)22 (17.5)170 (33.3)Colorectal
147 (23.1)35 (27.8)112 (22.0)Prostate
Gender and age
274 (43.1)51 (40.5)223 (43.7)Men, median age 66 years (range 23-92)
362 (56.9)75 (59.5)287 (56.3)Women, median age 58 years (range 24-88)
Index of Multiple Deprivation Quintile (1) a
119 (18.7)21 (16.8)98 (19.2)20% most deprived
123 (19.4)25 (20.0)98 (19.2)20-40% most deprived
96 (15.1)17 (13.6)79 (15.5)20% middle deprived
169 (26.6)38 (30.4)131 (25.7)20-40% least deprived
128 (20.2)24 (19.2)104 (20.4)20% least deprived
Email address
528 (83.0)120 (95.2)408 (80.0)Yes
108 (17.0)6 (4.8)102 (20.0)No
Collected from T1 participant self-report (n=540)
Ethnicity (1) a
523 (97.0)114 (95.0)409 (97.6)White British
10 (1.9)5 (4.2)5 (1.2)White other
6 (1.1)1 (0.8)5 (1.2)British minority ethnic group
Relationship status
29 (5.4)7 (5.8)22 (5.2)Single
411 (76.1)95 (79.2)316 (75.2)Married/Co-habiting/Civil partnership
52 (9.6)9 (7.5)43 (10.2)Widowed
33 (6.1)7 (5.8)26 (6.2)Separated/Divorced
15 (2.8)2 (1.7)13 (3.1)Other
Highest educational qualification (15) a
124 (23.6)15 (12.9)109 (26.7)No formal qualifications
137 (26.1)34 (29.3)103 (25.2)School qualifications
108 (20.6)26 (22.4)82 (20.0)University degree/s
65 (12.4)13 (11.2)52 (12.7)Vocational qualification/s
91 (17.3)28 (24.1)63 (15.4)Other
Employment status prior to cancer diagnosis
176 (32.6)35 (29.2)141 (33.6)Full-time employment
79 (14.6)19 (15.8)60 (14.3)Part-time employment
18 (3.3)3 (2.5)15 (3.6)Homemaker
241 (44.6)54 (45.0)187 (44.5)Retired
26 (4.8)9 (7.5)17 (4.0)Other
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aValue in parentheses is the number of missing values.
Figure 6. Flow chart of study recruitment.
Retention, Representativeness, and Questionnaire
Completion: Do All Patients Complete ePOCS
Questionnaires Fully and Repeatedly Over Time?
Almost all participants (95.1%, 605/636) were still enrolled in
the study at T3, with 12 deaths and 19 withdrawals accounting
for attrition. Participants who withdrew were older (mean 69.7,
SD 9.34 years) than those who stayed in study (mean 60.8, SD
10.97 years; t622=3.51, P<.001). Reasons for withdrawal
included IT-related issues (n=5) and lack of relevance (n=2)
(other, n=5; no reason given, n=7).
At T1, 85.1% of invited participants fully or partially completed
the questionnaire, and at T2 and T3, this value was 70.0% and
66.3% respectively (see Table 2). Of the 636 consented
participants, 597 were invited to complete the questionnaire at
all three time-points. The 39 participants not invited to complete
the questionnaire at all time-points included those who had
actively withdrawn from the study (n=19), who had died (n=12),
or for whom there was a technical error and a time-point
invitation was not generated (n=8). Of the 597 invited at all
time-points, 57.6% (344/597) fully completed the questionnaire
at all three time-points. Sixty-four (10.7%) completed no
questionnaire items at any of the time-points, and the remaining
31.7% (189/597) completed some proportion of the total number
of questionnaire items across the three time-points (ie, were
“partial” completers).
Age (P=.57), recruitment strategy (P=.10), and recruitment
location (P=.06) were not associated with full questionnaire
completion. Patients were more likely to fully complete the
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questionnaires at all three time-points if they were male (P=.02),
more affluent (P<. 01), were diagnosed with prostate cancer
(P=.01), or provided an email address (P=.02). Of patients who
fully completed the questionnaire at T1, 86.7% (431/497)
provided an email address, and at T2 and T3, this value was
86.0% (355/413) and 86.2% (338/392) respectively. Entering
these variables (missing value=1) into a binary logistic
regression analysis (full-completers versus partial and
noncompleters) resulted in the IMD quintile being the only
significant predictor in the model (χ28=25.41, P=.001, n=596),
with the three more socioeconomically deprived groups being
less likely to fully complete the questionnaires compared with
the most affluent group. The percentage of variance explained
by the model was minimal (Cox and Snell R square=0.042;
4.2% variance explained).
Of the 344 participants who fully completed the questionnaire
at all three time-points, 82 required no reminders (3 missing
values) (24.0%, 82/341). Ninety-two required one or more
reminders at all three time-points (27.0%, 92/341), and the
remaining 167 (49.0%, 167/341) received one or more reminders
at one or two time-points. Among participants who fully
completed all three questionnaires, age (P=.66), gender (P=1.0),
and IMD quintile (P=.11) were not associated with reminder
status (ie, received a reminder at any time-point versus needed
no reminder at any time-point). Having provided an email
address or not was related to reminder status, with those not
providing an email address being more likely to require a
reminder (missing values=3; χ21=4.750, P=.03, n=341).
The rates of missing data (ie, in fully completed PROMs, so
patients choosing “I would prefer not to answer this question”),
completion times, and internal reliability for each PROM at
each time-point are shown in Table 3. Missing data were
minimal, ranging from just 0.29% of EQ-5Dv2 items (T1) to a
still modest 3.15% of SDI-21 items (T2) and were largely
attributable to patients opting not to answer questions about
sexual matters. Time taken to complete individual PROMs
ranged from a median of 1:24 minutes:seconds (IQR=00:50)
for the 6-item EQ-5Dv2 (T3) to 12:46 minutes:seconds
(IQR=7:30) for the 66-item IPQ-R (T1). Overall, the PROMs
demonstrated acceptable internal reliability.
Patient Feedback: What Do Patients Think About
Providing Data via ePOCS?
Feedback questionnaires were sent to 599 of the 605 T3
participants (2 died and 4 withdrew during the T3 window).
Feedback was returned by 71.6% of participants (429/599) with
most returns from those who had completed all questionnaires
(69.9%, 300/429). Most participants reported that they found
it very easy or easy to get to the ePOCS website (item 6)
(T1=94.9%, 373/393; T2=98.1%, 352/359; T3=97.9%, 328/335),
to log on with their username and password (item 7) (T1=94.1%,
367/390; T2=96.4%, 347/360; T3=97.6%, 323/331), and to get
to the questionnaires (item 8) (T1=98.2%, 386/393; T2=91.6%,
329/359; T3=97.9%, 328/335) at all three time-points.
Participants who had required help with the system had mainly
received this from partners and family. Most participants favored
the electronic system over paper questionnaires (item 18)
(79.7%, 337/423), and most participants stated that they would
very likely or definitely continue using ePOCS to complete
questionnaires for the next 10-15 years if asked (item 17)
(86.2%, 361/419).
Most participants responded positively when asked what they
liked about the electronic system (item 13) (69.0%, 296/429):
“Easy and relaxed, able to complete at your own time, in your
own environment” [colorectal cancer patient, male, 62 years
old], “It was convenient and easy to use with the option of
reviewing answers (given) when required. I liked the option to
be able to leave the system but come back to complete later”
[prostate cancer patient, male, 65 years old], and “It was easy
to use (once I had logged on with help from my husband). I am
not very computer literate but could easily use the system”
[breast cancer patient, female, 47 years old].
In many cases participants indicated that they preferred ePOCS
to a paper system: “It is interactive. I liked receiving an email
telling me it was time to complete the questionnaire. I
appreciated receiving an email reminding me to complete the
questionnaire when I had not done so. I liked the ‘paperless’
system” [colorectal cancer patient, female, 46 years old], and
“Very easy to access. Less trouble than using pen and paper
and having to post the result” [colorectal cancer patient, male,
73 years old].
However, 27.0% (116/429) of participants did not provide a
response to item 13, and a small number of participants made
indifferent or negative comments (4.0%:17/429): “I did not
have any likes/dislikes about the system, it was like any other
questionnaire” [prostate cancer patient, male, 79 years old] and
“Nothing at all. I hate computers and prefer a written system
like this” [breast cancer patient, female, 56 years old].
For participants who indicated that they would have preferred
a paper system (item 18), the reasons mainly concerned lack of
computer knowledge, not having to rely on others for help, and
finding it easier to get an overview of a whole questionnaire:
“No experience of computers and related points” [colorectal
cancer patient, female, 88 years old], “I would prefer paper
because my daughter has a busy life and can’t always help me
and I couldn’t do it myself” [breast cancer patient, female, 51
years old], and “Easier to preview questions and review
answers” [colorectal cancer patient, male, 41 years old].
About a third of participants (33.8%, 145/429) commented on
how ePOCS might be changed (item 14), with most
improvement comments (75.9%, 110/145) concerning the
number, type, repetition, and layout of the questions: “Rather
too many questions and some feeling of overlap” [breast cancer
patient, female, 70 years old].
Although not asked to, some participants volunteered reasons
for their participation in the study, and altruism and a sense of
belonging to a community were commonly cited: “If it helps in
any way to achieve better treatment and after care, I’m all for
it” [colorectal cancer patient, male, 76 years old], and “I liked
answering the questions because I felt it gave me more of an
understanding of my condition and I didn’t feel like it was just
me with these symptoms” [breast cancer patient, female, 40
years old].
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Administration Burden: Is It Administratively Onerous
to Run the ePOCS System?
The Tracker database was easy and quick to use with all required
daily correspondence (invitations, reminders, thank-yous)
automatically generated and populated with the appropriate
patient’s details, ready for sending (after health status was
verified). As most participants provided an email address
(83.0%, 528/636), sending the required numerous reminders
(Table 2) was not onerous. There were proportionately few
occasions when participants contacted the ePOCS research team
(n=281), averaging 11 contacts per month. The reasons for the
patient inquiries are given in Figure 7.
Table 2. Questionnaire completion, reminders sent, and response rates at all time-points (number of items in questionnaire [number varies dependent
upon diagnostic group] T1=80, T2=102-108, T3=148-154).
Time 3 (T3)cTime 2 (T2)bTime 1 (T1)a
Invitation to complete the questionnaire not given
1250Died
1990Actively withdrew
350Technical error
602617636Invitation to complete the questionnaire given
394417520Questionnaire – fully completed
Reminders sent d
208 (52.8%)209 (50.1%)238 (45.8%)0
95 (24.1%)119 (28.5%)168 (32.3%)1
61 (15.5%)55 (13.2%)80 (15.4%)2
28 (7.1%)32 (7.7%)31 (6.0%)3
2 (0.5%)2 (0.5%)3 (0.6%)Missing
202521Questionnaire – partially completed
Reminders sent d
0 (0%)0 (0%)0 (0%)0
10 (50.0%)7 (28.0%)1 (4.8%)1
9 (45.0%)8 (32.0%)6 (28.6%)2
1 (5.0%)9 (36.0%)14 (66.7%)3
0 (0%)1 (4.0%)0 (0%)Missing
18817595Questionnaire – no items completed
Reminders sent d
0 (0%)0 (0%)0 (0%)0
5 (2.7%)10 (5.7%)3 (3.2%)1
4 (2.1%)5 (2.9%)5 (5.3%)2
177 (94.1%)160 (91.4%)87 (91.6%)3
2 (1.1%)0 (0%)0 (0%)Missing
Response rate (RR)
414/1140 (36.3%)442/1147 (38.5%)541/1152 (47.0%)RR1e
414/624 (66.3%)442/631 (70.0%)541/636 (85.1%)RR2f
aT1 window – between date of consent and 6 months post diagnosis.
bT2 window – a 6-week window for completion with the midpoint at 9 months post diagnosis.
cT3 window – a 6-week window for completion with the midpoint at 15 months post diagnosis.
dReminders were not sent to those who contacted the ePOCS team and actively withdrew after the invitation/reminder was sent.
eRR1=number of fully and partially completed questionnaires/all eligible patients approached minus those who died.
fRR2=number of fully and partially completed questionnaires/all eligible consented patients minus those who died.
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Table 3. Time to complete, missing data, and psychometric reliability for standard validated ePOCS PROMs (in addition to the standard validated
PROMs shown here, participants also completed other questions, eg, about sociodemographic information, employment, and the financial costs of
cancer).
Internal reliability, Cronbach αcMissing databCompletion timea, min:secFully completed,
nPROM (n items) α rangeN scales α≥.70Total %RangeMedian
.78–.907/7 (100%)0.8004:44–410:3212:46531T1IPQ-R (66)
n/an/a0.2900:39–29:0501:54526T1EQ-5Dv2 (6)
n/an/a0.3100:31–54:2001:30426T2
n/an/a0.4600:29–63:4201:24402T3
.83–.958/8 (100%)0.3902:59–39:1408:31432T2SF-36v2 (36)
.85–.958/8 (100%)0.3502:35–262:3707:44400T3
.72–.894/4 (100%)3.1501:17–29:1303:47423T2SDI-21 (21)
.69–.924/5 (80%)2.1301:24–32:5703:56196T2EORTC-QLQ-BR23 (23)
.64–.924/5 (80%)2.6801:14–40:0403:36183T3
.45–.902/5 (40%)1.3803:07–712:3306:35117T2EORTC-QLQ-CR29 (29)
.69–.833/5 (60%)1.3902:36–26:1205:45104T3
.41–.823/5 (60%)0.6802:10–28:4104:27117T2EORTC-QLQ-PR25 (25)
.43–.802/5 (40%)1.2302:01–44:4104:13111T3
.75–.9412/12 (100%)2.2503:36–288:5209:56407T3QLACS (47)
aCompletion time descriptive statistics are based on participants who started and completed a PROM on the same calendar day.
bMissing data (ie, patients’ choosing to respond “I would prefer not to answer this question”) per PROM is based on the number of patients who fully
completed that PROM.
cSpearman-Brown reliability coefficient for 2-item subscales.
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Figure 7. Reasons for participant inquiries to the ePOCS team over the study period.
Discussion
Principal Findings
This study has tested and demonstrated the technical and clinical
feasibility of an innovative electronic system for collecting
PROs online and linking them with clinical registry data. In
general, the results showed that the system informatics
performed successfully, demonstrated encouraging rates of
patient recruitment, retention, and questionnaire completion,
revealed predominately positive feedback from patients, and
showed a low administration burden involved in running the
system. However, patients who joined and stayed in the study
were not wholly representative of all invited/recruited patients.
The informatics underlying the ePOCS system demonstrated
successful proof-of-concept. The system successfully linked
PROs with registry data for 100% of patients. The set-up work
involved in establishing the linkage capacity was undertaken
over several weeks during system building by a member of the
registry IT team (but took approximately 2 working days
compressed). When the system is running, as in the current
study, an output of linked data can be instantaneously “pulled
off” the system. Importantly, the labor involved in the initial
linkage work is not impacted by the number of patients in the
system and would therefore remain modest even if use of the
system were scaled up considerably. The system also worked
efficiently with relatively few day-to-day running problems.
Speedy resolution of problems was possible due to the close
working relationship developed between all parties: the ePOCS
research team, the design teams of the QTool and Tracker
components of the ePOCS system, and the EHR and registry
IT teams. The modest number of IT-related inquiries from
patients mainly concerned confusion with some letters/numbers
in usernames and passwords and was easily resolved;
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importantly, this can be avoided when running the system in
the future by more careful design of the composition of
usernames and passwords.
Over half the patients invited joined up to use the ePOCS
system. The participation rate of 55.21% (636/1152) is
encouraging when compared with response rates for mailed
cancer patient surveys (31%-64%) [37], although in a recent
prospective longitudinal paper-based cancer patient survey using
a similar recruitment strategy to ePOCS, participation was as
high as 77% [38]. Among participants approached face-to-face
in clinic, rather than via letter or telephone, the recruitment rate
was considerably higher (61.4%) than the overall rate,
indicating, perhaps not surprisingly, that in-person invitations
to participate yield the best rates of patient consent. Although
it would thus be ideal to employ face-to-face clinic-based
recruitment, this is likely to be logistically and financially
unfeasible if the system is being used to collect data from very
large numbers of patients (eg, nationwide) and/or from numerous
geographically spread locations. In these cases, mailed
invitations, or a proportion of mailed invitations, will likely
have to be used.
Patients who declined to join the feasibility study were older
and less affluent (and patients who withdrew from the study
were also older) and most commonly cited IT reasons for
nonparticipation. Older age and socioeconomic deprivation are
characteristics commonly associated with study nonparticipation
[39], and these participation biases may have been exacerbated
in ePOCS as older age and deprivation are also associated with
lower computer/Internet use [23,40]. Encouragingly, there were
no differences between consenting and declining patients on
the basis of gender, diagnosis, or time post diagnosis. In the
long term, adoption of the Internet will be almost universal. In
the short term, to avoid bias and discrimination, online systems
can be used alongside other methods [24,41], such as
pen-and-paper, as done in PROFILES [14], where mailed
questionnaires complement the electronic system and
participation rates have been around 70% [15,16], or the
telephone, as tested for use in individual patient management
[42].
Almost all invited participants fully or partially completed all
the questionnaires (89.3%), despite the relatively large number
of items at each time-point (ie, between 80 and 154).
Deprivation was negatively associated with questionnaire
completion, and IT issues may also have influenced this,
although the low number of feedback questionnaires returned
from non/partial-responders makes this impossible to determine.
Receiving reminders led to improved completion of
questionnaires, although the impact diminished somewhat at
T2 and T3. Among participants who fully completed all three
questionnaires, patients who did not provide an email address
were more likely to need a reminder. Participants who receive
invitations in the mail have to make a special effort to go to a
computer, boot up, and find the ePOCS website prior to logging
on to complete questionnaires, whereas participants who receive
an email invitation are already online and can simply use the
weblink in the email to log on and complete questionnaires.
The time taken to complete individual PROMs varied
considerably (eg, 6-item EQ-5Dv2 at T1 ranged from 00:39 to
29:05 minutes:seconds), suggesting that some participants broke
off partway through to complete other activities. As has been
observed elsewhere (eg, [43]), the median completion time for
PROMs given at multiple time-points decreased with repeated
administrations (eg, EQ-5Dv2, SF-36v2). This may be due to
a learning effect, although as the time period between
questionnaires is considerable, it may also be a result of less
Internet-confident participants opting not to respond at later
time-points, thus reducing the overall median completion times.
Participant feedback was generally positive and endorsed the
ePOCS approach. Over 90% of participants found it very easy
or easy to access the ePOCS website, to log on, and to access
the questionnaires, at all three time-points. Encouragingly, most
respondents preferred the online ePOCS system to
pen-and-paper questionnaires, and the most common suggestions
for changing the system were concerned with the
questionnaires/PROMS administered (eg, number and repetition
of items) rather than the system itself. Impressively, 86.2% of
feedback respondents indicated that, if asked, they would likely
continue using the ePOCS system to complete questionnaires
in the long term. It must be kept in mind, however, that feedback
questionnaires were administered only to patients who joined
the study, and almost 70% of the returned feedback was from
patients who had engaged with the system and completed all
questionnaires. The positive feedback does not therefore provide
a full and balanced picture of what all patients would think
about such a system, and the results must be extrapolated
cautiously.
The ePOCS system was not administratively onerous to run.
The Tracker successfully automatically generated all the
administrative actions due each day (eg, the invitations,
reminders required). Checking the Tracker daily and sending
all the due correspondence, which was mostly via email, took
a member of the research team between just 15 and 30 minutes.
In the ePOCS study, 2 members of the research team shared
this task (to allow for sickness/holiday absence). The number
of participant inquiries received over the course of the study
averaged a modest 11 per month, even with 636 patients in
study, indicating that the time required to provide support to
patients using the system is not burdensome. This is similar to
the experience of the PROFILES system in which only around
2% of patients contact the PROFILES helpdesk [14]. Like any
such e-system, ePOCS could never be entirely automated, but
administration is relatively undemanding and could be run
day-to-day by trained administrative assistants. Importantly,
unlike a paper-based counterpart, ePOCS would remain
administratively undemanding and affordable if scaled up. The
low cost of online questionnaires is clearly demonstrated in a
study investigating the cost of survey response by mode of
administration; sizeable differences were found in the
administrative costs of paper-based, Web-based, and
mixed-mode surveys with estimates of costs per RR2 (as defined
in ePOCS) of US $4.78, $0.64, and $3.61 respectively [44].
ePOCS provides an infrastructure to routinely collect and link
PROs to clinical and cancer registration data. Preparatory
ePOCS work indicated patients’ disinclination to consent when
critical treatment decisions are being considered (not tested in
this study) or close to the time of diagnosis [45]. Reluctance to
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consent near diagnosis was not confirmed in this study.
Therefore, patients may be asked very early in their cancer
pathway (ideally face-to-face by their clinical team) to provide
PROs, as long as particular consideration is given at times of
critical decision making. If ePOCS or a similar system were to
be introduced from diagnosis onwards, the PROs data would
provide a real-time feed of the patient/survivor experience to
supplement data from other existing sources [46]. Additional
programming could enable linkage to other EHRs, registries,
or to the new English National Cancer Online Registration
Environment (EnCORE), which pulls patient-level data from
several local and national feeds.
IT is playing an increasing role in the delivery of high-quality
cancer care [47]. Feasibility of online PROs assessment for use
in individual patient management in clinical practice has been
demonstrated in two recent studies. In a study of online toxicity
reporting from home during routine chemotherapy [48], the
participation rate was 75%, and on average monthly compliance
was 83% and weekly compliance 62%. Although the consent
rate of 75% was considerably higher than the ePOCS consent
rate of 55.21% (636/1152), this may be accounted for by the
exclusion of non-Internet users in the study eligibility criteria.
In a study using an online system for collecting PROs in between
clinic visits [20], the participation rate was 68% and patients
completed a median of 71% of assigned questionnaires.
Although this consent rate is also higher than for ePOCS,
patients had the option to complete the questionnaires in clinic
using a laptop provided. The ePOCS system was designed and
built to link PROs with clinical and cancer registration data.
The approach could be used for data collected for clinical
purposes with a transfer of PROs to registries along with other
clinical data, subject to governance approvals. For example, a
system such as ePOCS could be introduced in routine practice
for individual patient management, close to diagnosis and during
treatment, as used in many centres [18]; be used in personalized
medicine, providing real-time data informing treatment and
symptom management strategies [19]; or be used in follow-up
where remote monitoring to identify patients’ late treatment
effects and supportive care needs would form part of
risk-stratified pathways of care [3,49]. Use of the ePOCS system
in clinical practice would, however, require substantial
additional software programming to enable live linkage with
the EHR, and the development of a training program for staff
as well as protocols/algorithms for the use and interpretation of
PROs by clinicians. In addition, PROMs used in patient care
tend to be different in scope and psychometrics to those needed
for epidemiological research, and some may not be
interchangeable [7,50,51]. The PROMs used in this study were
chosen for their applicability in survivorship research and
performed well. If ePOCS were rolled out for individual
survivorship management in addition to epidemiological data
collection, a mixed combination of carefully reviewed PROMs
will have to be agreed upon.
Strengths and Limitations
To our knowledge, this is the first study to test and report on
the feasibility of a system like ePOCS. Strengths of the study
include multisite recruitment, the large number of patients
invited to participate (over 1000), and the examination of
patients’ use of the system on multiple, longitudinal occasions.
We also consider an important strength to be the focus on
technical and administrative feasibility which, alongside patient
consent and response rates, are of key importance for those
seeking to use and run a system like ePOCS.
The principal limitation of the study is that we were unable to
test the system in a more authentic context. Unavoidably, in
order to obtain patients’ informed consent, the current study
was presented to patients as being about the ePOCS system.
However, future studies that use the ePOCS system will be
presented to patients with emphasis on the PROs to be collected
and analyzed, and the ePOCS system will be mentioned only
secondarily as the data collection tool. It will be important to
examine patient recruitment, retention, and response rates in
future PROs studies that simply use the ePOCS system rather
than aim to test it. The second notable limitation concerns the
minimal feedback obtained from patients who declined
participation and who consented but did not complete
questionnaires. In health information technology (HIT) research
generally there is a lack of studies exploring the perspectives
and experiences of patients who choose not to engage with HIT
and/or who withdraw participation. We are currently planning
a study with such patients, aimed at understanding and
overcoming modifiable barriers to patients’ acceptance and use
of HIT.
Conclusions
Routine collection of PROs is integral for planning
patient-centred, compassionate, and personalized health care.
This study has shown that the ePOCS system performs well, is
accepted by the majority of patients, and is an efficient means
to collect and collate PROs data at scale. Although IT usage is
not currently universal, every year more patients will become
Internet users. Until then, and for those who choose not to
engage with e-systems, conventional alternatives will also have
to be offered. This should not hold back plans for introducing
systems such as ePOCS, as the majority of patients are keen to
engage and provide information they believe will help future
cancer patients.
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